Global drugmakers are in no hurry to leave the Russian market, still considering the local market as one of the most promising for their growth, according to recent statements made by Mikhail Murashko, head of the Russian Ministry of Health.
According to him, despite sanctions and the ever-growing isolation of the country in the international arena, in Russia in recent years, new production of medicines has been launched almost every month including those with the participation of foreigners.
Mr Murashko commented: "Foreign suppliers of drugs are in no hurry to leave the market. I must say that for them this is a significant volume of sales, and the market with the capacity of our country is a fairly a decent market for them.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze